Inactive Instrument
Kancera AB Stock
Stocks
NOVKAN
SE0015658570
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -43.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Olin
CEO | Chief Executive Officer | 68 | 2010-05-04 |
Robert Edfors
CTO | Chief Tech/Sci/R&D Officer | - | 2024-08-31 |
Maria Sahlberg
CMP | Compliance Officer | 44 | 2024-05-07 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | - | |
Thomas Olin
BRD | Director/Board Member | 68 | 2010-05-04 |
| Director/Board Member | 60 | 2018-05-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/25/21 | Free | Chairman | 33,150 | 0.0594% | ||
| 5/21/21 | Buy | Director | 7,710 | - | ||
| 5/21/21 | Others | Chairman | 18,183 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -43.95% | -50.98% | - | - | 330K | |
| -4.31% | -6.62% | +65.79% | +98.02% | 72.12B | |
| -4.19% | +1.05% | +52.79% | +85.53% | 65.85B | |
| -3.22% | +23.17% | +1.75% | -5.23% | 29.28B | |
| -1.42% | -3.38% | -5.99% | +465.34% | 27.47B | |
| +3.29% | +3.33% | +50.84% | +13.19% | 26.7B | |
| -1.81% | +0.38% | +34.52% | -18.33% | 20.06B | |
| +5.36% | +4.61% | +270.18% | +415.10% | 18.22B | |
| -1.43% | -4.98% | +9.73% | +509.70% | 16.4B | |
| +0.87% | +4.26% | +41.21% | +150.80% | 13.4B | |
| Average | -5.08% | +5.35% | +57.87% | +190.46% | 32.17B | |
| Weighted average by Cap. | -2.01% | +3.13% | +54.55% | +149.43% |
Employees
5
Calendar
